Insider Trading May 1, 2026 04:58 PM

Rogers Corp Executive Executes Common Stock Sale Amid Recent Price Strength

SVP Brian Keith Larabee liquidates $112,805 in shares as ROG approaches 52-week highs following a year of significant gains.

By Marcus Reed ROG
Rogers Corp Executive Executes Common Stock Sale Amid Recent Price Strength
ROG

Brian Keith Larabee, serving as the Senior Vice President and General Manager of EMS for Rogers Corp (NASDAQ: ROG), has completed a sale of company common stock. The transaction, which took place on May 1, 2026, involved the disposal of 830 shares. This insider activity occurs during a period of notable price appreciation for the company's equity, as the stock trades in close proximity to its 52-week high.

Key Points

  • SVP Brian Keith Larabee sold 830 shares at $135.91 per share, totaling $112,805.
  • Rogers Corp stock has achieved a 113% return over the past year and is trading near its 52-week high of $136.14.
  • Q1 2026 earnings met EPS expectations at $0.75, though total sales of $201 million missed the $206.4 million forecast.

In a recent filing regarding insider transactions, Brian Keith Larabee, who holds the position of SVP & GM - EMS at Rogers Corp (NASDAQ: ROG), has sold a portion of his holdings in the company. The transaction was executed on May 1, 2026, consisting of 830 shares of common stock. The sale was conducted at a price point of $135.91 per share, resulting in total proceeds of $112,805.

Following the completion of this specific transaction, Mr. Larabee maintains a direct ownership stake in Rogers Corp consisting of 5,515 shares of common stock. This movement comes at a time when ROG is trading near its 52-week high of $136.14, following what has been a substantial 113% return over the previous year.


Key Market Observations

  • Stock Performance and Valuation: The company's stock has demonstrated significant momentum, yielding a 113% return over the last twelve months. Despite this recent climb toward its 52-week high of $136.14, analysis indicates that the stock remains undervalued relative to its Fair Value.
  • Balance Sheet Strength: A critical component of the company's current financial position is its liquidity profile; Rogers Corp currently maintains a balance sheet where cash holdings exceed total debt levels.
  • Earnings Consistency: In its Q1 2026 earnings report, the company demonstrated steady performance by meeting earnings per share (EPS) expectations with a result of $0.75.

Risks and Uncertainties

  • Revenue Targets: While EPS met analyst projections, total sales for Q1 2026 reached $201 million, which fell short of the anticipated $206.4 million target. This discrepancy between actual revenue and forecasted expectations represents a point of scrutiny for the company's top-line growth.
  • Market Positioning: Although the stock has seen massive returns, investors are monitoring whether current market positioning can be sustained given that no recent analyst upgrades or downgrades have been recorded to provide new directional sentiment.

As of the latest reporting, there have been no significant corporate developments reported by Rogers Corporation, including any mergers or acquisitions. The company's recent trajectory continues to be defined by its ability to align with EPS forecasts despite missing revenue benchmarks.

Risks

  • Revenue shortfall: Total sales for Q1 2026 were below the anticipated $206.4 million.
  • Lack of recent analyst movement: There have been no recent analyst upgrades or downgrades to signal shifts in market sentiment.

More from Insider Trading

Marcus & Millichap Director Executes Substantial Common Stock Purchase May 4, 2026 Patterson-UTI CEO Executes Multi-Million Dollar Stock Sale Amidst Year-to-Date Surge May 4, 2026 Snowflake Director Michael Speiser Executes $7.18 Million in Stock Sales May 4, 2026 Edwards Lifesciences Executive Executes Stock Transactions Amid Recent Financial Growth May 4, 2026 Entrada Therapeutics President and COO Executes Stock Sale via Rule 10b5-1 Plan May 4, 2026